组内成员
许海恒
发布时间:2026年03月10日
浏览次数:

电子邮箱:hhxu@xzhmu.edu.cn

许海恒,博士,讲师。2024年,获南京大学博士学位。入选江苏省“双创博士”。研究方向为肿瘤原位制备CAR-T技术开发及治疗实体瘤研究,以第一/通讯作者(含共同)在Advanced Materials (IF=27.4)、Nature Biomedical Engineering (IF=28.1)、Advanced Science (IF=14.1)等期刊发表SCI论文6篇。授权中国发明专利2项。主持江苏省卫健委医学科研项目、江苏省高校自然科学研究面上项目,江苏省高校科协青年科技人才培育计划等项目,参与国家重点研发计划。担任中国民族医药协会肿瘤学分会委员、江苏省高等学校科学技术协会会员。

文章:

1.Haiheng Xu, Shuqin Xiong, Yiyun Chen, Qingsong Ye, Nan Guan, Yiqiao Hu, Jinhui Wu*. Flagella of tumor - targeting bacteria trigger local hemorrhage to reprogram tumor‐associated macrophages for improved antitumor therapy[J].Advanced Materials, 2023, 35(38):2303357.(IF=27.4)

2.Wenguang Wang#,Haiheng Xu#, Qingsong Ye#, Feng Tao, Ian Wheeldon, Ahu Yuan, Yiqiao Hu*, Jinhui Wu*. Systemic immune responses to irradiated tumours via the transport of antigens to the tumour periphery by injected flagellate bacteria[J].Nature Biomedical Engineering, 2022, 6(1): 44-53.(IF=28.1, co-first author)

3.Yucheng Liu#, Junhong Yao#, Jiaxin Deng, Minjie Zhou, Kaiyue Shen, Shishuo Sun, Xiaoge Gao, Qing Zhang*,Haiheng Xu*.Attenuated Bacteria-Based Tumor Therapy: Clinical Application Risks, Marketing Approval Restrictions, and Coping Strategies[J].Advanced Science,2026: e17730. (IF=14.1)

4.Deyuan Zheng#, Junhong Yao#,Haiheng Xu#*, Shuqin Xiong, Qingsong Ye, Yiyun Chen, Chuan Zhao, Min Zhang, Xuehui Rui*, Jinhui Wu*.Bacteria outer membrane-based oxygen gels alleviate tumor hypoxia for enhanced systemic immune response of radiotherapy[J].Science China-Materials,2026, 69(3): 1729-1740. (IF=7.4, co-first author and co-corresponding author)

5.Haiheng Xu, Shuqin Xiong, Deyuan Zheng, Lan An, Yiyun Chen, Lei Wang*, Xuehui Rui*, Jinhui Wu*.Tumor intracellular self-assembled nanoparticles induced by bacteria elicited erythrocyte infiltration realize antitumor efficacy of zoledronate[J].Nano Research,2025, 18(9): 94907827. (IF=9.0)

6.Haiheng Xu, Yiqiao Hu*, Jinhui Wu*. Flagellated bacterial porter for in situ tumor vaccine[J].Microbial Cell, 2022, 9(9): 158-161.(IF=4.6)

研究组